![Sofosbuvir and daclatasvir - Hessel - 2016 - British Journal of Clinical Pharmacology - Wiley Online Library Sofosbuvir and daclatasvir - Hessel - 2016 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/df8ba603-0db3-4d37-80a6-0ce5b63130fb/bcp13011-fig-0001-m.jpg)
Sofosbuvir and daclatasvir - Hessel - 2016 - British Journal of Clinical Pharmacology - Wiley Online Library
![Sofosbuvir/Velpatasvir/Voxilaprevir: A Highly Effective Option for Retreatment of Hepatitis C in Difficult-to-treat Patients - Poonam Mathur, Shyamasundaran Kottilil, Eleanor Wilson, 2019 Sofosbuvir/Velpatasvir/Voxilaprevir: A Highly Effective Option for Retreatment of Hepatitis C in Difficult-to-treat Patients - Poonam Mathur, Shyamasundaran Kottilil, Eleanor Wilson, 2019](https://journals.sagepub.com/cms/10.3851/IMP3264/asset/images/large/10.3851_imp3264-fig1.jpeg)
Sofosbuvir/Velpatasvir/Voxilaprevir: A Highly Effective Option for Retreatment of Hepatitis C in Difficult-to-treat Patients - Poonam Mathur, Shyamasundaran Kottilil, Eleanor Wilson, 2019
![Advances in hepatitis B therapeutics - Vicente Soriano, Pablo Barreiro, Edward Cachay, Shyamasundaran Kottilil, José V. Fernandez-Montero, Carmen de Mendoza, 2020 Advances in hepatitis B therapeutics - Vicente Soriano, Pablo Barreiro, Edward Cachay, Shyamasundaran Kottilil, José V. Fernandez-Montero, Carmen de Mendoza, 2020](https://journals.sagepub.com/cms/10.1177/2049936120965027/asset/images/large/10.1177_2049936120965027-fig1.jpeg)
Advances in hepatitis B therapeutics - Vicente Soriano, Pablo Barreiro, Edward Cachay, Shyamasundaran Kottilil, José V. Fernandez-Montero, Carmen de Mendoza, 2020
![Structural basis for the severe adverse interaction of sofosbuvir and amiodarone on L-type Cav channels - ScienceDirect Structural basis for the severe adverse interaction of sofosbuvir and amiodarone on L-type Cav channels - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0092867422013708-fx1.jpg)
Structural basis for the severe adverse interaction of sofosbuvir and amiodarone on L-type Cav channels - ScienceDirect
![Sofosbuvir, a novel nucleotide analogue inhibitor used for the treatment of hepatitis C virus - Summers - 2014 - Journal of Pharmacy and Pharmacology - Wiley Online Library Sofosbuvir, a novel nucleotide analogue inhibitor used for the treatment of hepatitis C virus - Summers - 2014 - Journal of Pharmacy and Pharmacology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/cfb6dd6e-a858-40b8-8fd0-52bfcd8b2a68/jphp12294-fig-0001-m.jpg)
Sofosbuvir, a novel nucleotide analogue inhibitor used for the treatment of hepatitis C virus - Summers - 2014 - Journal of Pharmacy and Pharmacology - Wiley Online Library
![Directly Acting Antivirals (DAAs) for the Treatment of Chronic Hepatitis C Virus Infection in Liver Transplant Patients: “A Flood of Opportunity” - American Journal of Transplantation Directly Acting Antivirals (DAAs) for the Treatment of Chronic Hepatitis C Virus Infection in Liver Transplant Patients: “A Flood of Opportunity” - American Journal of Transplantation](https://www.amjtransplant.org/cms/attachment/043b74ea-68d4-4150-ac47-8aca0557f04e/gr1_lrg.jpg)
Directly Acting Antivirals (DAAs) for the Treatment of Chronic Hepatitis C Virus Infection in Liver Transplant Patients: “A Flood of Opportunity” - American Journal of Transplantation
![Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study | British Journal of Cancer Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I study | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-018-0244-1/MediaObjects/41416_2018_244_Fig1_HTML.png)